Novartis (NVS) 2026 Earnings Outlook: Risks & Opportunities
Novartis faces a nuanced path in 2026, balancing new therapies with cost discipline. This guide breaks down the key d...
An overview of index funds with the lowest fees for retirement in 2024, highlighting how fees affect long-term returns and what to consider.
27,284 articlesNovartis faces a nuanced path in 2026, balancing new therapies with cost discipline. This guide breaks down the key d...
IonQ and D-Wave fell more than 5% last week as investors tempered bets on quantum stocks amid broader market strength...
A Bermuda-based platform focused on institutional crypto options closes a $30 million round led by CMT Digital, with ...
A single cloud ETF has become the dominant vehicle for exposure as cloud stocks swing in 2026, prompting a shift away...
Millions of Iranians have been uprooted by ongoing fighting, threatening household budgets and testing the limits of ...
The Midwest multifamily investment sector heating is gaining momentum as rates stabilize and rental demand strengthen...
Meta Platforms has shown strong top-line momentum, but rising AI-related costs and shifting margins could pressure ea...
Stocks all-time highs still attract buyers as earnings momentum and AI-driven demand support another leg up. Here's t...
Maze Therapeutics stock still faces mixed signals from the market: a strong rally after a March dip, paired with a no...
Vitalik Buterin announces a structural reset for the Ethereum Foundation to reduce selling pressure and sharpen gover...
Canadian travel has cooled as cross-border tensions and higher fuel prices curb bookings for Maine inns and regional ...
Trump questions a policy move by the Fed as Warsh steps into his first FOMC chair role, with markets recalibrating af...